U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

NCI has initiated a pilot study to address the feasibility of using multi-cancer detection, or MCD, tests in future randomized controlled trials.

July 18, 2025

Vol.51 No.28

Cancer Policy

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

July 11, 2025

Vol.51 No.27

By Jacquelyn Cobb

Funding Opportunities

NCI, SITC immunotherapy fellowship calls for applications

NCI and the Society for Immunotherapy of Cancer are accepting applications for a one-year fellowship program beginning in July 2026.

July 11, 2025

Vol.51 No.27

Guest Editorial

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.

July 03, 2025

Vol.51 No.26

By George J. Weiner and Elizabeth M. Jaffee

Guest Editorial

Building cancer care resilience through international observerships: Lessons from Ukraine

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges. Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

June 27, 2025

Vol.51 No.25

By Nataliya Kovalchuk, Andriy Beznosenko, Vitaliy Y. Poylin, Rostyslav Semikov, Arman Kacharian, Douglas Davis, Nataliya Uboha, Natalka Suchowerska, Viktor Iakovenko, Jacqueline Hart, Mark Poznansky, Darya Kizub and Nelya Melnitchouk

In Brief

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

RWJBarnabas Health and Rutgers Cancer Institute officially opened the doors of the 12-story, 520,000 square-foot, state-of-the-art Jack & Sheryl Morris Cancer Center—the state’s only freestanding, comprehensive cancer hospital, one of just 13 in the nation.

June 27, 2025

Vol.51 No.25

U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression

YOU MAY BE INTERESTED IN

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Supreme Court lifts lower-court freeze on RIFs

NCI, SITC immunotherapy fellowship calls for applications

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

Building cancer care resilience through international observerships: Lessons from Ukraine

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Renew today!

Subscriber content

Never miss an issue!

Login

U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression

YOU MAY BE INTERESTED IN

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Supreme Court lifts lower-court freeze on RIFs

NCI, SITC immunotherapy fellowship calls for applications

As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures

Building cancer care resilience through international observerships: Lessons from Ukraine

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Never miss an issue!

Login

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures